Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Ranbaxy Laboratories Ltd.

BSE: 500359 | NSE: RANBAXY | Series: NA | ISIN: INE015A01028 | SECTOR: Pharmaceuticals

BSE Live

Apr 01, 16:00
859.90 0.00 (0.00%)
Volume
No Data Available
0
  • Prev. Close

    859.90

  • Open Price

    814.90

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Ranbaxy Laboratories is not traded on BSE in the last 30 days

NSE Live

Apr 01, 15:59
859.80 0.00 (0.00%)
Volume
No Data Available
0
  • Prev. Close

    859.80

  • Open Price

    814.70

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    859.80 (9924)

Ranbaxy Laboratories is not traded on NSE in the last 30 days

Financials

Profit & Loss account of Ranbaxy Laboratories (in Rs. Cr.) Mar 14 Dec 12 Dec 11  
  15 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 13,084.34 12,280.81 9,989.05  
Less: Excise/Sevice Tax/Other Levies 44.02 27.91 19.05  
Revenue From Operations [Net] 13,040.32 12,252.89 9,970.00  
Total Operating Revenues 13,268.49 12,459.73 10,328.99  
Other Income 182.83 290.74 255.92  
Total Revenue 13,451.32 12,750.46 10,584.91  
EXPENSES  
Cost Of Materials Consumed 2,827.72 2,060.93 2,299.46  
Purchase Of Stock-In Trade 2,288.55 1,886.31 1,322.01  
Operating And Direct Expenses 0.00 0.00 0.00  
Changes In Inventories Of FGWIP And Stock In Trade -288.02 112.88 -287.92  
Employee Benefit Expenses 2,577.46 1,928.42 1,645.08  
Finance Costs 557.26 303.60 306.42  
Depreciation And Amortisation Expenses 476.16 320.25 394.02  
Other Expenses 4,889.61 4,666.03 3,857.83  
Total Expenses 13,328.74 11,278.41 9,536.90  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 122.58 1,472.05 1,048.00  
Exceptional Items -864.33 -227.16 -3,734.49  
Profit/Loss Before Tax -741.76 1,244.89 -2,686.48  
Tax Expenses-Continued Operations  
Current Tax 366.40 291.26 195.96  
Less: MAT Credit Entitlement 0.00 0.00 0.00  
Deferred Tax -25.58 2.65 0.97  
Other Direct Taxes 0.00 0.00 0.00  
Total Tax Expenses 331.45 293.90 196.93  
Profit/Loss After Tax And Before ExtraOrdinary Items -1,073.21 950.99 -2,883.42  
Profit/Loss From Continuing Operations -1,073.21 950.99 -2,883.42  
Profit/Loss For The Period -1,073.21 950.99 -2,883.42  
Minority Interest 2.00 -9.64 -9.72  
Consolidated Profit/Loss After MI And Associates -1,085.25 922.76 -2,899.73  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) -26.00 22.00 -69.00  
Diluted EPS (Rs.) -26.00 22.00 -69.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 0.00 0.07  
Tax On Dividend 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347